Clinical Trial Update: Evaluation of a Simple-Prep Controlled Embolic [NA]

View source ↗

Summary

This clinical trial update indicates ongoing evaluation of a simple-prep controlled embolic device; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Angiomyolipoma
• Renal Cell Carcinoma

Snippet

Sponsor: Fluidx Medical Technology, Inc. | Conditions: Embolization, Vascular Tumor | NA | Status: ACTIVE_NOT_RECRUITING